DrugDec 28, 2022
Oxcarbazepine Tablets 600mg recall — FDA D-0085-2023
Presence of foreign substance
Class IIFDA: TerminatedSUN PHARMACEUTICAL INDUSTRIES Inc.
Latest records
Latest recalls — page 297
The newest recall records with useful source details are listed here.
DrugDec 28, 2022
Quinapril Tablets USP, 20 mg (90 pack) recall — FDA D-0089-2023
CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.
Class IIFDA: TerminatedLupin Pharmaceuticals Inc.
VehicleDec 22, 2022
Acura TLX bead recall — NHTSA campaign 22V950000
Honda (American Honda Motor Co.) is recalling certain 2022 Acura TLX vehicles. The tires may have sustained cuts and tears during the sorting process, which can result in tire damage.
beadHonda (American Honda Motor Co.)
VehicleDec 22, 2022
Chrysler camera recall — NHTSA campaign 22V947000
Chrysler (FCA US, LLC) is recalling certain 2022 Ram Promaster Chassis Cab and incomplete vehicles equipped with an analog rearview camera. The analog rearview camera is the incorrect type…
cameraChrysler (FCA US, LLC)
DrugDec 21, 2022
BayCare Integrated Service Center, LLC /dba Iohexol (300 mg Iodine/mL), 2.4 g Iodine/8 ml recall — FDA D-0086-2023
Labeling: Label Error on Declared Strength: syringes mislabeled as 300 mg iodine/mL contained product 350 mg iodine/mL
Class IFDA: TerminatedBayCare Integrated Service Center, LLC /dba BayCare…
DrugDec 21, 2022
SODIUM BICARBONATE 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL recall — FDA D-0079-2023
Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.
Class IFDA: TerminatedExela Pharma Sciences LLC
DrugDec 21, 2022
Exela Pharma Sciences 8.4% Sodium Bicarbonate Injection, USP 50 mEq/50 mL (1 mEq/mL) 50 mL recall — FDA D-0080-2023
Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.
Class IFDA: TerminatedExela Pharma Sciences LLC
DrugDec 21, 2022
Lacosamide Oral Solution, USP, CV, 10mg/mL recall — FDA D-0094-2023
Failed Excipient Specifications: out of specification result observed for p-Hydroxybenzoic Acid content
Class IIIFDA: TerminatedCamber Pharmaceuticals, Inc.
VehicleDec 19, 2022
BMW critical fasteners recall — NHTSA campaign 22V942000
BMW of North America, LLC (BMW) is recalling certain 2023 X5 sDrive40i, X5 M50i and X5 xDrive 45e vehicles. One of the four bolts that connects the backrest to the driver's seat frame may…
critical fastenersBMW of North America, LLC
VehicleDec 15, 2022
General Motors front passenger recall — NHTSA campaign 22V929000
General Motors, LLC (GM) is recalling certain 2023 Chevrolet Equinox and GMC Terrain vehicles equipped with ventilated front passenger seats. The Occupant Classification System may not…
front passengerGeneral Motors, LLC
DrugDec 14, 2022
RemedyRepack Desmopressin Acetate Tablet, 0.2 mg, 100-count box recall — FDA D-0077-2023
Subpotent Drug: repackaged product was recalled by the manufacturer for subpotency.
Class IIFDA: TerminatedRemedyRepack Inc.
DrugDec 14, 2022
SODIUM CHLORIDE 0.9% Sodium Chloride Injection, USP, Each 100 mL contains: SODIUM CHLORIDE recall — FDA D-0075-2023
Lack of Assurance of Sterility: Leakage of 0.9% Sodium Chloride for Injection, 1L, 12pk Saline Solution.
Class IIFDA: OngoingFresenius Medical Care Holdings, Inc.
VehicleDec 14, 2022
Bronco side impact recall — NHTSA campaign 22V928000
Ford Motor Company (Ford) is recalling certain 2021-2022 Bronco vehicles. The right or left side impact sensors may not be properly secured to the vehicle.
side impactFord Motor Company
VehicleDec 14, 2022
Chevrolet Malibu frame and members recall — NHTSA campaign 22V923000
General Motors, LLC (GM) is recalling certain 2022-2023 Chevrolet Malibu vehicles. The front impact bar, a structural portion of the vehicle frame, may not be properly welded to the front…
frame and membersGeneral Motors, LLC
VehicleDec 8, 2022
Forte arm recall — NHTSA campaign 22V906000
Kia America, Inc. (Kia) is recalling certain 2023 Forte vehicles. Due to a manufacturing error, the front left steering knuckle may crack, which can result in a loss of steering control.
armKia America, Inc.
VehicleDec 8, 2022
General Motors lighting control module software recall — NHTSA campaign 22V903000
General Motors, LLC (GM) is recalling certain 2020-2023 Cadillac CT4 and CT5; 2021-2023 Buick Envision; and 2022-2023 Cadillac Escalade and Escalade ESV, Chevrolet Silverado 1500, Suburban,…
lighting control module softwareGeneral Motors, LLC
VehicleDec 8, 2022
Chrysler hinge and attachments recall — NHTSA campaign 22V904000
Chrysler (FCA US, LLC) is recalling certain 2019-2022 Ram 1500, 2500, and 3500 pickup trucks. The tailgate may not latch properly due to misaligned tailgate strikers, which could result in…
hinge and attachmentsChrysler (FCA US, LLC)
VehicleDec 8, 2022
Ascent interior/under dash recall — NHTSA campaign 22V907000
Subaru of America, Inc. (Subaru) is recalling certain 2019-2022 Ascent vehicles. The ground bolt that secures the ground terminal of the Positive Temperature Coefficient (PTC) heater may…
interior/under dashSubaru of America, Inc.
DrugDec 7, 2022
Daytrana recall — FDA D-0071-2023
Defective Delivery System: Recalled lot was found to be out of specification for shear. Shear is an attribute related to the adhesive properties of the transdermal patches.
Class IIFDA: OngoingNoven Pharmaceuticals Inc.
DrugDec 7, 2022
Acella Pharmaceuticals Sodium Sulfacetamide 10% Sulfur 4% Cleansing Pads, Net weight 3.7g recall — FDA D-0074-2023
Subpotent drug: Out of specification for assay at the end-of-shelf-life 24-month period.
Class IIIFDA: TerminatedAcella Pharmaceuticals, LLC
VehicleDec 5, 2022
Model Y subframe/mounting bracket recall — NHTSA campaign 22V895000
Tesla, Inc. (Tesla) is recalling certain 2023 Model Y vehicles. The front suspension lateral link fasteners may not have been properly attached to the sub-frame.
subframe/mounting bracketTesla, Inc.
DrugNov 30, 2022
Pantoprazole Sodium for Delayed-Release Oral Suspension*40 mg* suspension in apple juice or recall — FDA D-0068-2023
Discoloration
Class IIFDA: TerminatedSUN PHARMACEUTICAL INDUSTRIES Inc.
DrugNov 30, 2022
Phenytoin Sodium Injection, USP 100 mg/2 mL, NDC 42192-614-02 recall — FDA D-0069-2023
Labeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode.
Class IIIFDA: TerminatedAcella Pharmaceuticals, LLC
DrugNov 30, 2022
Phenytoin Sodium Injection, USP, 250 mg/5 mL, NDC 42192-614-05 recall — FDA D-0070-2023
Labeling: Not elsewhere classified; the product is being recalled because of customer complaints that the primary vial label was missing a barcode.
Class IIIFDA: TerminatedAcella Pharmaceuticals, LLC
Browse by month
Recent recall archives
Browse recent months with enough recall history for useful comparison.
August 2026149 records · 4 categoriesJuly 2026371 records · 4 categoriesJune 2026375 records · 4 categoriesMay 2026340 records · 4 categoriesApril 2026415 records · 4 categoriesMarch 2026190 records · 4 categoriesFebruary 2026331 records · 4 categoriesJanuary 2026212 records · 4 categoriesDecember 2025389 records · 4 categoriesNovember 2025326 records · 4 categoriesOctober 2025455 records · 4 categoriesSeptember 2025285 records · 4 categories